Please use this identifier to cite or link to this item: http://earsiv.odu.edu.tr:8080/xmlui/handle/11489/1980
Full metadata record
DC FieldValueLanguage
dc.contributor.authorAytemir, Kudret-
dc.contributor.authorBayrak, Tulin-
dc.contributor.authorCanpolat, Ugur-
dc.contributor.authorKarabulut, Erdem-
dc.contributor.authorKaya, Ergun Baris-
dc.contributor.authorOto, Ali-
dc.contributor.authorOzer, Necla-
dc.contributor.authorOzkan, Adem-
dc.contributor.authorOzkara, Asuman-
dc.contributor.authorSunman, Hamza-
dc.contributor.authorTokgozoglu, Lale-
dc.contributor.authorYorgun, Hikmet-
dc.date.accessioned2022-08-16T11:39:51Z-
dc.date.available2022-08-16T11:39:51Z-
dc.date.issued2018-
dc.identifier.urihttp://doi.org/10.5603/CJ.a2017.0111-
dc.identifier.urihttp://earsiv.odu.edu.tr:8080/xmlui/handle/11489/1980-
dc.description.abstractBackground: Several studies have investigated the effects of cardiac resynchronization therapy (CRT) on heart failure (HF), but none have evaluated the pathophysiological pathways involved in a single group of patients. Therefore, this study aims to assess the long-term effects of CRT on six different pathophysiological pathways involved in the process of HF by the use of surrogate biomarkers. Methods: In a group 44 patients with HF, six groups of biomarkers were measured, both at baseline and 1 year after CRT implantation: inflammation (interleukin [IL]-4, IL-6, tumor necrosis factor [TNF]-alpha, high sensitive C-reactive protein [hsCRP]); oxidative stress (myeloperoxidase [MPO], oxidized low-density lipoprotein [oxLDL], uric acid); extracellular matrix (ECM) remodeling (matrix metalloproteinase [MMP]-2 and -9, galectin-3, procollagen III N-terminal propeptide [prokol-3NT]); neurohormonal pathways (endothelin-1, chromogranin-A); myocyte injury (troponin T, creatine kinase MB fraction [CK-MB]), myocyte stress (B-type natriuretic peptide [BNP]). CRT responders were defined as patients with >= 15% reduction in left ventricular end-systolic volume at 12 months post-CRT. Results: At 1-year follow-up, 72.7% (n = 32) of the patients were categorized as CRT responders. In these patients, the levels of IL-6, MPO, oxLDL, MMP-2, galectin-3, troponin T, and BNP were significantly reduced as compared to baseline values. While the biomarkers for myocyte stress (effect size = 0.357; p = 0.001), ECM remodeling (effect size = 0.343; p = 0.015) and oxidative stress (effect size = 0.247; p = 0.039) showed a significant change in the CRT responders during follow-up, the biomarkers for other pathophysiological pathways did not show a significant alteration. Conclusions: In the present study, a significant reduction was only observed in the biomarkers of myocardial stress, ECM remodeling, and oxidative stress among all the CRT responder subjects.en_US
dc.language.isoengen_US
dc.publisherVIA MEDICA, UL SWIETOKRZYSKA 73, 80-180 GDANSK, POLANDen_US
dc.relation.isversionof10.5603/CJ.a2017.0111en_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectcardiac resynchronization therapy; responder; pathophysiology; biomarkersen_US
dc.titleEvaluating the effects of cardiac resynchronization therapy on pathophysiological pathways of heart failure using surrogate biomarkersen_US
dc.typearticleen_US
dc.relation.journalCARDIOLOGY JOURNALen_US
dc.contributor.departmentOrdu Üniversitesien_US
dc.contributor.authorID0000-0002-4250-1706en_US
dc.identifier.volume25en_US
dc.identifier.issue1en_US
dc.identifier.startpage42en_US
dc.identifier.endpage51en_US
Appears in Collections:Temel Tıp Bilimleri

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.